CN
120-93-4
应用筛选条件
关键词:'120-93-4'
显示 1-30 共 435 条结果 关于 "120-93-4" 范围 技术文档
Scalability of Mobius®Single-Use Bioreactors
91
92
93
94
95
96
97
98
99
100
0 2 4 6 8 10 12
%
V
ia
bi
lit
y
V
ia
bl
e
The Effective Use of Protein Kinase Inhibitors
22 11 15 19 0 1 77 8 53 94 89 87 116
91 104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103
69
109
Poster: Protein Capture with Salt Tolerant CEX
high
salt
40 93 0 79 1.5 2.0 100 0 1.0
Conven-
tional
CEX, plus
inline
dilution
90 93 8 53 1.5 2.0 100 21000 18.0
120
58
4
0
20
Product Information Sheet - Z4250
and Fiore, J.V., Science, 127, 756-757 (1958).
3. Pillemer, L., Blum, L., et al., Science, 120, 279 (1954).
4. Pillemer, L., et al., J. Experimental Medicine, 103, 3 (1956).
See also:
Huber, A.R.
The Effective Use of Protein Kinase Inhibitors
22 11 15 19 0 1 77 8 53 94 89 87 116
91 104 71 50 3 4 13 3 95 78 38 65 34 91 93 96 66 39 93 79 94 103
69
109
Influence of Environmental Sample Pre-Storage on Counting Results
figure 1.
3
140
0
20
40
60
80
100
120
16-18h RT 2h 4-8°C 6h 4-8°C 16-18h 4-8°C 72h 4-8°C
S. aureus 144 93
Data Sheet - N6786
, Proc. Natl. Acad. Sci. USA, 93,
13014-13019 (1996).
2. Huppert, S.S. et al., Nature, 405, 966-970 (2000).
3. Milner, L.A. et al., Blood, 93, 243-248 (1999).
4. Ray, W.J. et al., Proc. Natl
PureFlex™ and PureFlex™ Plus White Paper
removed from the containers
on days: 1, 7, 30, 60, 90 and 120. Aliquots of the
initial solutions were used as controls.
3
Step 4. Extractables in the
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
Irisin FSTL1 OSM IL-6 FGF21 Musclin
1:4 dil 64 79 139 94 110 89 67 99 79 114
1:8 dil 49 54 150 98 111 86 79 89 66 124
1:16 dil 93 79 120 118 89
Monitoring low dose API blend uniformity with Parteck® M
69 75 81 87 93 99
Lab data
Calibration Set: Calculated vs Lab Data
105 111 117 123 129 135
129
135
123
117
111
105
99
M
od
el
p
re
di
ct
ed
d
at
Data Sheet - A1848
the recombinant
protein migrates at approximately 120 kDa in SDS-
PAGE under reducing conditions. Human and mouse
ALCAM show an overall identity of 93%.2
Human ALCAM (activated leukocyte cell adhesion
Development of Multiplex Immunoassay Panels for Simultaneous Quantification of Bone Metabolism Markers using Luminex xMAP Technology
OPG 95 90 — —
Insulin 92 101 92 91
Leptin 87 93 93 93
ACTH 117 92 115 85
IL-6 86 87 89 90
TNFα 122 92 133 93
Osteocalcin — 99 — 97
PRECISION:
Intra-assay 4%
Inter-assay <11%
Rat Bone Panels: Assay Characteristics
Mid-Infrared-based quantitation of highly modified proteins, labeled peptides and peptidomimetics
spectroscopy in the determination of protein
structure, Critical Rev. Biochem. Mol. Biol. 1995;
30:95-120.
4. F. Cadet, S. Garrigues and M. de la Guardia,
Quantitative analysis, infrared, Encyclopedia of
Data Sheet - P4954
Wattenburg, E. V., et al., Cancer Res., 49, 5837
(1989)
4. Bonnard, C., et al., Carcinogenisis, 9, 2245 (1988)
5. Lazzaro, M., et al., Endocrinology, 120, 1338
(1987)
6. Nagase, H., and Karaki, H., J. Pharmacol
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
mL Control 2 485 – 1007 pg/mL
Eotaxin Control 1 105 – 217 pg/mL IL-1ra Control 1 93 – 194 pg/mL
MultiScreen Filter Plates with Ultracel®-10 Membrane
Human 92 77 61 49 47 64 81 93
10 www.millipore.com
Spin Sample Average Ultrafiltrate Volume (µL) by Row
Time Type A B C D E F G H
60 ABS 87
PAB - An Enhanced Sanitization Option for ProSep Chromatography Media MM
0.1 M Ac 1% BA
pH 5.2
21 °C 100 93 90 96 91
PAB solution was 120 mM phosphoric, 167 mM acetic acid and
2.2 % (v/v) benzyl alcohol.
Resin was ProSep®-vA High Capacity media.
AstellCompleteRange 2010
Pulsed Free Steaming
l Optional Single or 3 Phase
Power requirement
(on 120 & 133L models)
Standard features
| 120 | 153 | 247 | 290 | 344 | Litres
Swiftlock Front Loading Autoclaves
www.astell.com
Data Sheet - SAB4200573
Heiskala, M., et al., Traffic, 2, 93-98 (2001).
2. Rahner, C., et al., Gastroenterol., 120, 411-422
(2001).
3. Hou, J., et al., Annu. Rev. Physiol., 75, 479-501
(2013).
4. Hewitt, K.J., et al., BMC Cancer
Eshmuno®P Chromatography Resins Data Sheet
operational flexibility for Eshmuno® P resins. Figures 4 and
5, and table 1 illustrate these benefits.
0
20
40
60
80
100
120
0 2 4 6 8 10
%
R
Product Information Sheet-MAK465
Catalogue Number MAK465A
• Dye Reagent 120 µL
Catalogue Number MAK465B
• Enzyme A 1 vial
Catalogue Number MAK465C
• Enzyme B 120 µL
Catalogue Number
Quality Control Range Sheet- HSTC-108 and HSTC-208
Cytokine QC Level Expected Range Units
GM-CSF Control 1 183 – 381 pg/mL IL-10 Control 1 45 – 93 pg/mL
Control 2 684 – 1422 pg/mL Control 2 176 – 366 pg/mL
Data Sheet - SAB4200574
Heiskala, M., et al., Traffic, 2, 93-98 (2001).
2. Rahner, C., et al., Gastroenterol., 120, 411-422
(2001).
3. Hou, J., et al., Annu. Rev. Physiol., 75, 479-501
(2013).
4. Hewitt, K.J., et al., BMC
Inactivación de desinfectantes utilizando placas de contacto ICR con medio de cultivo TSA con diferentes neutralizantes
Ingredientes:
119
55
153
93
146
97
90
77
92
76
85
96
R
ec
up
er
ac
ió
n
(%
)
Microorganismo
160
120
Data Sheet - I5032
Complementation cloning of
NEMO, a component of the IκB kinase complex
essential for NF-κB activation. Cell, 93, 1231-1240
(1998).
3. Ii, Y., et al., Identification of a cell protein (FIP-3) as
a modulator
Data Sheet - T8828
., Cell, 126, 107-120 (2006).
2. Laptenko, O., and Prives, C., Cell Death Different.,
13, 951-961 (2006).
3. Liu, B. et al., Free Radic. Biol. Med., 44, 1629-1535
(2008).
4. Green, D.R., and
Product Information Sheet - A6132
3. Mancilla, M., et al., Phytochemistry, 23(7), 1397-
1400 (1984).
4. Molnar, J., and Lorand, L., Arch. Biochem.
Biophys., 93(2), 353-363 (1961).
5. Kettlun, A., et al., Phytochemistry, 21(3)
Aldrich Polymer Products Application - Ionx
®
21,653-4 IR-120 Plus(H) 8 G 16-50 H 45 120 1.9 4.4 0-14
22,435-9 IR-120 Plus - G 16-50 Na 45 120 1.9 4.4 0-14
27,427-5 IRP-69 - - 25-150µm Na 10 - - - -
21,638-0 15 - Mp 16-50 H
Product Information Sheet - M9195
Kähäri, V.M., and Saarialho-Kere, U., Exp.
Dermatol., 6, 199 (1997).
4. Halbert, I., et al., Proc. Natl. Acad. Sci., USA, 93,
9748 (1996).
5. Chandler, S., et al., J. Neuroimmunol., 72, 155
1/15